Client or Matter Name
Client: SK Capital Partners
Matter: Project Artemis
Deal Description
We represented SK Capital Partners, a private investment firm focused in the pharmaceutical sector, in the acquisition of Apotex Pharmaceutical Holdings Inc. (“Apotex”), a Canadian pharmaceutical company that produces high-quality, affordable medicines across all major therapeutic areas for patients around the world.
The acquisition included several subsidiaries of Apotex, including entities in Canada, the United States, Mexico, India, China, among others.
Jurisdiction
Canada
Governing Law
Canada
Deal Duration, Date of Closing / Signing
Signing: September 22, 2022
Closing: April 1, 2023
Practice Area
Mergers and Acquisitions
Team GC
Jorge Cervantes – Partner.
Alberto Bustamante – Counsel.
Andrés Yépiz – Associate.
Diego Hernández – Associate.
Other practice areas involved during diligence.